Hemophagocytosis Clinical Trial
Official title:
Hemophagocytosis in Critically Ill Adult Patients With Cytopenias
The purpose of the study is to find out whether non-responsiveness to therapeutic recombinant human granulocyte colony-stimulation factor (rhG-CSF) is associated with hemophagocytosis in critically ill adult patients with cytopenias.
In children with bi- or pancytopenia, hemophagocytosis is known as life-threatening hemophagocytic lymphohistiocytosis (HLH). The purpose of the study is to find out whether adult patients with bicytopenia or pancytopenia fulfilling the clinical HLH criteria used in children reflect life-threatening hemophagocytosis and whether hemophagocytosis is associated with responsiveness to recombinant human granulocyte colony-stimulation factor (rhG-CSF) or not. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03546101 -
Early Detection of Epstein-Barr Virus Related Disease.
|
||
Completed |
NCT02401932 -
Retrospective Analysis for Patients With Hemophagocytosis in Bone Marrow
|
N/A |